FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Glyburide Metformin Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Impax Laboratories (New 08/25/2017)

Company Contact Information:
877-994-6729

Presentation Posting Date Related Information
1.25 mg/250 mg; 100 tablets/bottle (NDC 0115-1648-01) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.
1.25 mg/250 mg; 500 tablets/bottle (NDC 0115-1648-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.
2.5 mg/500 mg; 100 tablets/bottle (NDC 0115-1649-01) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.
2.5 mg/500 mg; 500 tablets/bottle (NDC 0115-1649-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.
5 mg/500 mg; 100 tablets/bottle (NDC 0115-1650-01) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.
5 mg/500 mg; 500 tablets/bottle (NDC 0115-1650-02) 08/25/2017 A business decision was made to discontinue manufacture of the drug product. The anticipated final date for marketing is September 2017.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English